Inter- and intra-patient sequence diversity among parainfluenza virus-type 1 nucleoprotein genes

Virus Genes

Volumn 14, Issue 2, 1997, Pages 153-156

  Dave, Vibhuti P ^a   Hetherington, Seth V ^a   Portner, Allen ^a,c   Leggiadro, Robert J ^b   Hurwitz, Julia L ^a,c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b LE BONHEUR CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Diversity; Nucleoprotein; Parainfluenza virus; Patient; Vaccine

Indexed keywords

VIRUS NUCLEOPROTEIN;

AMINO ACID SEQUENCE; ANTIGENIC VARIATION; ARTICLE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PARAINFLUENZA VIRUS; PRIORITY JOURNAL; RNA VIRUS INFECTION; VIRUS GENE;

AMINO ACID SEQUENCE; BASE SEQUENCE; DNA PRIMERS; DNA, VIRAL; GENES, VIRAL; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEOPROTEINS; PARAINFLUENZA VIRUS 1, HUMAN; RESPIROVIRUS INFECTIONS; SEQUENCE HOMOLOGY, AMINO ACID; VARIATION (GENETICS); VIRAL PROTEINS; VIRAL VACCINES;

HUMAN PARAINFLUENZA VIRUS 1; RNA VIRUSES;

EID: 0030861089     PISSN: 09208569     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007973402749     Document Type: Article

References (19)

1. Henrickson K.J., Kuhn S.M., and Savatski L.L., Clin Infect Dis 18, 770-779, 1994.
2. Chanock R.M., and McIntosh K. in Fields B.N., and Knipe D.M. (eds). Virology. Raven Press, New York, 1990, pp. 963-986.
3. Kingsbury D.W. in Fields B.N., and Knipe D.M. (eds). Virology Raven Press, New York, 1990, pp. 945-962.
4. Welliver R., Wong D.T., Choi T.-S., and Ogra P.L., J Pediatrics 101, 180-187, 1982.
5. Chin J., Magoffin L., Shearer L.A., Schieble J.H., and Lennette E.H., American J Epidemiology 899, 449-463, 1969.
6. Smith F.S., Portner A., Leggiadro R.J., Turner E.V., and Hurwitz J.L., Virology 205, 453-461, 1994.
7. Dave V.P., Allan J.E., Slobod K.S., Smith S.F., Ryan K., Powell U., Portner A., and Hurwitz J.L., Virology 199, 376-383, 1994.
8. Sangster M., Smith F.S., Coleclough C., and Hurwitz J.L., Virology 212, 13-19, 1995.
9. Hurwitz J.L., Soike K.F., Sangster M.Y., Portner A., Sealy R.E., Dawson D.H., and Hurwitz J.L., Vaccine, in press, 1997.
10. Ranjit R., Matsuoka Y., Burnett T.L., Glaze B.J., and Compans R.W., J Infect Dis 162, 746-749, 1990.
11. Murphy B.R., and Webster R.G., in Fields B.N., and Knipe D.M. (eds). Virology. Raven Press, New York, 1990, pp. 1091-1152.
12. Vanlandschoot P., Beirnaert E., Dewilde S., Saelens X., Bestebroer T., De Jong J., Jou W.M., and Fiers W., Virology 212, 526-534, 1995.
13. Coelingh K.V., and Winter C.C., J Virol 64, 1329-1334, 1990.
14. Hetherington S.V., Watson A.S., Scroggs R.A., and Portner A., J Infect Dis 169, 248-252, 1994.
15. Cole G.A., Katz J.M., Hogg T.L., Ryan K.W., Portner A., and Woodland D.L. J Virol 68, 6863-6370, 1994.
16. Kast W.M., Bronkhorst A.M., De Waal L.P., Melief C.J.M., J Exp Med 164, 723-738, 1986.
17. Kast W.M., Roux L., Curren J., Blom H.J.J., Voordouw A.C., Meloen R.H., Kolakofsky D., Melief C.J.M., Proc Natl Acad Sci USA 88, 2283-2287, 1991.
18. Hou S., Doherty P.C., Zijlstra M., Jaenisch R., Katz J.M., J Immunol 149, 1319-1325, 1992.
19. Lyn D., Gill D.S., Scroggs R.A., Portner A., J Gen Virol 72,